Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human) includes N-terminal acetylation and stereochemical inversion that modify charge, rigidity, and receptor-contact motifs. The sequence supports studies of growth factor peptide folding and binding. Its amphipathic nature aids in structural analysis. Applications include peptide engineering, motif mapping, and biosynthesis research.
CAT No: G09020
CAS No:93942-91-7
Synonyms/Alias:93942-91-7;DTXSID60745607;93942-95-1;Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human);PUBCHEM_71308697;DA-50138;Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide;Acetyl-(tyr1,d-arg2)-grf(1-29)amide(human);(AC-TYR1,D-ARG2)-GRF (1-29) AMIDE (HUMAN);
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.